Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CLSD

Clearside Biomedical (CLSD)

Clearside Biomedical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLSD
DateTimeSourceHeadlineSymbolCompany
19/12/202423:05GlobeNewswire Inc.Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, EyeNASDAQ:CLSDClearside Biomedical Inc
25/11/202423:05GlobeNewswire Inc.Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United StatesNASDAQ:CLSDClearside Biomedical Inc
13/11/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
13/11/202408:05GlobeNewswire Inc.Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/11/202401:05GlobeNewswire Inc.Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular EdemaNASDAQ:CLSDClearside Biomedical Inc
06/11/202423:05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
05/11/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLSDClearside Biomedical Inc
04/11/202423:05GlobeNewswire Inc.Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of DirectorsNASDAQ:CLSDClearside Biomedical Inc
31/10/202422:05GlobeNewswire Inc.Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024NASDAQ:CLSDClearside Biomedical Inc
22/10/202422:05GlobeNewswire Inc.Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
09/10/202422:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
09/10/202421:30GlobeNewswire Inc.Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary OutcomesNASDAQ:CLSDClearside Biomedical Inc
27/08/202421:05GlobeNewswire Inc.Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
13/08/202406:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLSDClearside Biomedical Inc
13/08/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
13/08/202406:05GlobeNewswire Inc.Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/08/202421:05GlobeNewswire Inc.Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:CLSDClearside Biomedical Inc
01/08/202421:05GlobeNewswire Inc.Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024NASDAQ:CLSDClearside Biomedical Inc
30/07/202406:05GlobeNewswire Inc.Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in ChinaNASDAQ:CLSDClearside Biomedical Inc
24/07/202421:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
23/07/202402:00GlobeNewswire Inc.Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ETNASDAQ:CLSDClearside Biomedical Inc
11/07/202421:05GlobeNewswire Inc.Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory BoardNASDAQ:CLSDClearside Biomedical Inc
27/06/202421:05GlobeNewswire Inc.Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug DeliveryNASDAQ:CLSDClearside Biomedical Inc
12/06/202421:05GlobeNewswire Inc.Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit MeetingNASDAQ:CLSDClearside Biomedical Inc
21/05/202421:05GlobeNewswire Inc.Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®NASDAQ:CLSDClearside Biomedical Inc
11/05/202406:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CLSDClearside Biomedical Inc
10/05/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
10/05/202406:05GlobeNewswire Inc.Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
09/05/202406:15GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:CLSDClearside Biomedical Inc
30/04/202421:05GlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024NASDAQ:CLSDClearside Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:CLSD